Protagenic Therapeutics, Inc.\new — Form D/A
Protagenic Therapeutics, Inc.\new of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2016-04-22. The offering totals $5.5M, of which $5.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-04-22
- Form: D/A
- Accession: 0001144204-16-095773
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $5.1M
- Remaining: $364K
- Investors: 49
- Date of first sale: 2016-02-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-257945
Issuer
- Name: Protagenic Therapeutics, Inc.\new
- CIK: 0001022899
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Phone: 212-994-8200
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Gregory H Ekizian | Director | New York, NY |
| Joshua K Silverman | Director | New York, NY |
| Mark Dyne | Director | Sherman Oaks, CA |
| Raymond Musci | Director | Sherman Oaks, CA |
| Raymond Musci | Executive Officer | Sherman Oaks, CA |
| Garo H Armen | Director | New York, NY |
| Garo H Armen | Executive Officer | New York, NY |
| Robert B Stein | Director | New York, NY |
| Alexander K Arrow | Executive Officer | New York, NY |
| Joshua B Silverman | Director | New York, NY |
| Brian J Corvese | Director | New York, NY |
| Khalil B Barrage | Director | New York, NY |
| Robert H Ziroyan | Executive Officer | New York, NY |
| Lawrence Burstein | Director | NEW YORK, NY |
| Jerome Chazen | Director | New York, NY |
| Stuart Goldfarb | Director | New York, NY |
| Stuart Goldfarb | Executive Officer | New York, NY |
| Thomas Plotts | Executive Officer | New York, NY |
Other filings by this issuer (6)
More